Sign In
Buy NARI
$79.97
+0 (+0%)
At Close: May 16, 2025
Shareholders of Inari Medical, Inc. Should Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your Rights - NARI
07:50am, Wednesday, 15'th May 2024
NEW YORK, NY / ACCESSWIRE / May 15, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, f
SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements re: Inari Medical business and prospects, resulting in its stock trading at inflated prices.
NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 12, 2024 to fil
Investors in Inari Medical, Inc. Should Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your Rights – NARI
09:15pm, Tuesday, 14'th May 2024
NEW YORK, NY / ACCESSWIRE / May 14, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, f
Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – NARI
08:15pm, Tuesday, 14'th May 2024
NEW YORK, NY / ACCESSWIRE / May 14, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, f
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inari Medical, Inc.(NARI) Shareholders
07:15pm, Tuesday, 14'th May 2024
NEW YORK, NY / ACCESSWIRE / May 14, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, f
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Inari Medical, Inc. (NARI) Investors
06:04pm, Tuesday, 14'th May 2024
NEW YORK--(BUSINESS WIRE)-- #Investigation--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on
NEW YORK, NY / ACCESSWIRE / May 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Inari Medical, Inc. ("Inari Medical, Inc.") (NASDAQ:NARI) concerning possible v
NEW YORK , May 14, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Inari Medical,
Inari Medical, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - NARI
03:15pm, Tuesday, 14'th May 2024
NEW YORK, NY / ACCESSWIRE / May 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Inari Medical, Inc. ("Inari Medical, Inc.") (NASDAQ:NARI) concerning possible v
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Inari Medical, Inc. (NARI)
03:15pm, Tuesday, 14'th May 2024
NEW YORK, NY / ACCESSWIRE / May 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Inari Medical, Inc. ("Inari Medical, Inc.") (NASDAQ:NARI) concerning possible v
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Inari Medical, Inc. (NASDAQ
Inari Medical (NARI) Q1 Earnings Miss Estimates, OpEx Rises
12:01pm, Wednesday, 01'st May 2024
Inari Medical's (NARI) first-quarter results witness an increase in revenues with dismal bottom-line performance. Gross margins contract while the companies continue to incur operating losses.
Inari Medical, Inc. (NARI) Q1 2024 Earnings Call Transcript
03:32am, Wednesday, 01'st May 2024
Inari Medical, Inc. (NASDAQ:NARI ) Q1 2024 Earnings Conference Call April 30, 2024 4:30 PM ET Company Participants John Hsu - Vice President, Investor Relations Drew Hykes - Chief Executive Officer Mi
Inari Medical, Inc. (NARI) Reports Q1 Loss, Tops Revenue Estimates
06:46pm, Tuesday, 30'th Apr 2024
Inari Medical, Inc. (NARI) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.04 per share a year ago.
